about
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease modelsA Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced deathBiphasic mechanisms of neurovascular unit injury and protection in CNS diseasesBee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse modelSpontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein ExpressionValue of genetic models in understanding the cause and mechanisms of Parkinson's diseaseMemory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice.Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease.Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133)Transcriptional regulation by nicotine in dopaminergic neurons.Mice lacking major brain gangliosides develop parkinsonismA guide to neurotoxic animal models of Parkinson's diseaseThe hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.Tricyclic Antidepressants Amitriptyline and Desipramine Induced Neurotoxicity Associated with Parkinson's Disease.Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidineExecutive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primateMetabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.alpha-Synuclein: a therapeutic target for Parkinson's disease?Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies.Drosophila melanogaster as a model organism of brain diseasesThe angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonismAnimal models of human amyloidoses: are transgenic mice worth the time and trouble?β-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia.Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice.Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular studyLLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression.Inflammation in neurodegenerative diseases.Cellular repair strategies in Parkinson's disease.Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.New animal models of Parkinson's disease.
P2860
Q24315670-DE8A9669-F5C7-4E77-A8EE-8879EC26B730Q24644712-85A5AA55-354C-4C70-8373-C8C355859F94Q26827146-305B210D-6E21-4D65-BBA3-0A6CC024A4EEQ27324290-BC843E01-3A78-454D-B95A-F8FF68F49F43Q30359033-205CFBAA-6971-4BAB-9EC0-060C6ECBBFB0Q30412016-64AF9373-4B95-45C1-BBCA-B51E3B091309Q30470435-0D590CEB-CBB3-4686-9547-EC8118F3D4DFQ30538394-29091D02-34E2-44B8-A681-01E8B2193E27Q33553317-38E42E16-BE12-4E4B-805C-7FF419B15780Q33562727-7BCCD941-A450-4049-BD77-206B0C357977Q33773655-6413B0AE-2608-4132-BB17-F73CAA6D96C5Q33815568-E61C6E54-50EF-462E-846E-6D71A627FB01Q33819387-F95822CA-9210-4489-8EBF-07C5094F16E0Q34314094-FEDC70EA-77F8-405A-BACD-F69C68EBB965Q34933695-1E80C4F6-1357-45B3-AF9D-D8078CDC959CQ35161290-DC1FD3CF-8CD0-4810-81DD-F6A04EC1732AQ35603488-D8DCC4EC-34DC-4665-8EDB-0B6F8E0D5ABBQ35894167-8753D625-1521-45CC-9D0A-3F3AF99B82DBQ35922870-37A45E61-61D8-4C2C-8FE5-3BD5C612D8C5Q35988894-66CA43E8-7F42-4D22-BCBF-FBD4CBC05E4DQ36019710-29BFB5D1-3E8D-4369-914A-7011618570ACQ36200063-ABE38E61-1C95-4534-B100-910DD4832798Q36435001-5BE0BF1C-011E-420F-A9A5-5B4465270C3CQ36596353-3B1A9707-A6F0-4395-8637-4D0D082213C3Q36999607-648D2D8B-0032-4935-AFFB-3406F708298DQ37070916-F8F36130-1967-4675-997C-0EFFC8BD3951Q37136665-607ED99B-04D2-472A-9D1D-37F667117A7EQ37139826-3C3C1CAD-06C2-451E-A855-E165D1D390ADQ37467929-7F1C9D01-AA3C-4325-98D4-2CF22F670DBEQ37560167-4AFBE727-FA1C-4599-AF9A-529F104C1F06Q37578793-C0C71EC8-B7D7-4D25-BED4-CC8BC7130EB1Q37582397-B5FFE91B-1642-4CF0-B708-4F1D62B5DA95Q37621012-5E27D3BF-2FB9-4F8C-87F2-C1598AE5D467Q37725727-F899ECCC-484C-4FFD-9E5C-4163DE273F75Q37729481-D432D8DB-F46F-40A5-A319-3AAC6B0BC656Q37766302-FDC71460-921B-40F8-95E6-477C066DEDE8Q37823336-059BB6AD-F4F8-4B1E-A7B3-37BB298B0CADQ37875484-23ED0E62-7784-4702-995F-9A6259E60880Q37880260-FE6E4BFC-00E4-425B-B215-DD23EB3001C9Q37951958-60AE0C7F-E49B-4688-86FE-A1B28A843D6A
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Animal models of Parkinson's disease progression
@en
type
label
Animal models of Parkinson's disease progression
@en
prefLabel
Animal models of Parkinson's disease progression
@en
P2860
P1476
Animal models of Parkinson's disease progression
@en
P2093
Gloria E Meredith
Patricia K Sonsalla
P2860
P2888
P304
P356
10.1007/S00401-008-0350-X
P577
2008-02-14T00:00:00Z